BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ye F, Huang J, Wang H, Luo C, Zhao K. Targeting epigenetic machinery: Emerging novel allosteric inhibitors. Pharmacol Ther 2019;204:107406. [PMID: 31521697 DOI: 10.1016/j.pharmthera.2019.107406] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 de Barrios O, Parra M. Epigenetic Control of Infant B Cell Precursor Acute Lymphoblastic Leukemia. Int J Mol Sci 2021;22:3127. [PMID: 33803872 DOI: 10.3390/ijms22063127] [Reference Citation Analysis]
2 Sandoval JE, Ramabadran R, Stillson N, Sarah L, Fujimori DG, Goodell MA, Reich N. First-in-Class Allosteric Inhibitors of DNMT3A Disrupt Protein-Protein Interactions and Induce Acute Myeloid Leukemia Cell Differentiation. J Med Chem 2022. [PMID: 35866897 DOI: 10.1021/acs.jmedchem.2c00725] [Reference Citation Analysis]
3 Borges LDF, Batista LL, Malta SM, Rodrigues TS, Silva JRDC, Venturini G, Pereira ADC, Guedes PHG, Ueira-Vieira C, Bonetti AM. 10-hydroxy-2E-decenoic acid (10HDA) does not promote caste differentiation in Melipona scutellaris stingless bees. Sci Rep 2021;11:9882. [PMID: 33972627 DOI: 10.1038/s41598-021-89212-5] [Reference Citation Analysis]
4 Liu Z, Li Y, Chen H, Lai HT, Wang P, Wu SY, Wold EA, Leonard PG, Joseph S, Hu H, Chiang CM, Brasier AR, Tian B, Zhou J. Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site. J Med Chem 2022. [PMID: 34982556 DOI: 10.1021/acs.jmedchem.1c01851] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
5 Tan Z, Li T, Lei H, Zhai X. An update on allosteric modulators as a promising strategy targeting histone methyltransferase. Pharmacol Res 2021;172:105865. [PMID: 34474102 DOI: 10.1016/j.phrs.2021.105865] [Reference Citation Analysis]
6 Yang J, Cao MX, Hu WY, Wei YY, Hu TJ. Sophorasubprosrate polysaccharide suppress the inflammatory reaction of RAW264.7 cells infected with PCV2 via regulation NF-κB/MAPKs/c-Jun signal pathway and histone acetylation modification. Int J Biol Macromol 2020;159:957-65. [PMID: 32442564 DOI: 10.1016/j.ijbiomac.2020.05.128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Davidovich C, Zhang Q. Allosteric regulation of histone lysine methyltransferases: from context-specific regulation to selective drugs. Biochem Soc Trans 2021;49:591-607. [PMID: 33769454 DOI: 10.1042/BST20200238] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhu Y, Ye F, Zhou Z, Liu W, Liang Z, Hu G. Insights into Conformational Dynamics and Allostery in DNMT1-H3Ub/USP7 Interactions. Molecules 2021;26:5153. [PMID: 34500587 DOI: 10.3390/molecules26175153] [Reference Citation Analysis]
9 Ni D, Chai Z, Wang Y, Li M, Yu Z, Liu Y, Lu S, Zhang J. Along the allostery stream: Recent advances in computational methods for allosteric drug discovery. WIREs Comput Mol Sci. [DOI: 10.1002/wcms.1585] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
10 Liang Z, Zhu Y, Liu X, Hu G. Role of protein-protein interactions in allosteric drug design for DNA methyltransferases. Adv Protein Chem Struct Biol 2020;121:49-84. [PMID: 32312426 DOI: 10.1016/bs.apcsb.2019.12.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Meng F, Liang Z, Zhao K, Luo C. Drug design targeting active posttranslational modification protein isoforms. Med Res Rev 2021;41:1701-50. [PMID: 33355944 DOI: 10.1002/med.21774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
12 Tang G, Yuan J, Wang J, Zhang YZ, Xie SS, Wang H, Tao Z, Liu H, Kistler HC, Zhao Y, Duan CG, Liu W, Ma Z, Chen Y. Fusarium BP1 is a reader of H3K27 methylation. Nucleic Acids Res 2021;49:10448-64. [PMID: 34570240 DOI: 10.1093/nar/gkab844] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Itoh Y, Takada Y, Yamashita Y, Suzuki T. Recent progress on small molecules targeting epigenetic complexes. Current Opinion in Chemical Biology 2022;67:102130. [DOI: 10.1016/j.cbpa.2022.102130] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Zhao Y, Guan Y, Zhao F, Yu T, Zhang S, Zhang Y, Duan Y, Zhou X. Recent strategies targeting Embryonic Ectoderm Development (EED) for cancer therapy: Allosteric inhibitors, PPI inhibitors, and PROTACs. European Journal of Medicinal Chemistry 2022;231:114144. [DOI: 10.1016/j.ejmech.2022.114144] [Reference Citation Analysis]
15 Zhang Y, Rong D, Li B, Wang Y. Targeting Epigenetic Regulators with Covalent Small-Molecule Inhibitors. J Med Chem 2021;64:7900-25. [PMID: 33599482 DOI: 10.1021/acs.jmedchem.0c02055] [Reference Citation Analysis]
16 Prieto-Martínez FD, Medina-Franco JL. Current advances on the development of BET inhibitors: insights from computational methods. Adv Protein Chem Struct Biol 2020;122:127-80. [PMID: 32951810 DOI: 10.1016/bs.apcsb.2020.06.002] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Gally F, Sasse SK, Kurche JS, Gruca MA, Cardwell JH, Okamoto T, Chu HW, Hou X, Poirion OB, Buchanan J, Preissl S, Ren B, Colgan SP, Dowell RD, Yang IV, Schwartz DA, Gerber AN. The MUC5B-associated variant rs35705950 resides within an enhancer subject to lineage- and disease-dependent epigenetic remodeling. JCI Insight 2021;6:144294. [PMID: 33320836 DOI: 10.1172/jci.insight.144294] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Liang Z, Zhu Y, Long J, Ye F, Hu G. Both intra and inter-domain interactions define the intrinsic dynamics and allosteric mechanism in DNMT1s. Comput Struct Biotechnol J 2020;18:749-64. [PMID: 32280430 DOI: 10.1016/j.csbj.2020.03.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
19 Takada Y, Yamashita Y, Itoh Y, Suzuki T. Medicinal Chemistry Research on Targeting Epigenetic Complexes. J Synth Org Chem Jpn 2022;80:664-75. [DOI: 10.5059/yukigoseikyokaishi.80.664] [Reference Citation Analysis]
20 Nemtsova MV, Kalinkin AI, Kuznetsova EB, Bure IV, Alekseeva EA, Bykov II, Khorobrykh TV, Mikhaylenko DS, Tanas AS, Strelnikov VV. Mutations in Epigenetic Regulation Genes in Gastric Cancer. Cancers (Basel) 2021;13:4586. [PMID: 34572812 DOI: 10.3390/cancers13184586] [Reference Citation Analysis]